Authors



Calvin Eng, MD

Latest:

Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.


Sibyl Cherian, PharmD

Latest:

Establishing Standards of Care for Amiodarone Monitoring in an Outpatient Setting

Implementing a quality-improvement project that allows for education and interdisciplinary collaboration among pharmacists, cardiologists, and primary care providers can improve rates of amiodarone monitoring.


Han Nguyen, PharmD Candidate

Latest:

Summary of Current SARS-CoV-2 Vaccine Trials

Many clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.


Jeffrey B. Weilburg, MD

Latest:

Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL Control

Evaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.



Bimal V. Patel, PharmD, MS

Latest:

E-Prescribing With Decision Support Is Associated With Improvements in Medication Adherence

This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.


Julia Spiridigliozzi, PharmD

Latest:

An Introduction to Pharmaceutical Industry Fellowships

With the current increase in pharmacy school enrollment contributing to a more competitive job market, novel and nontraditional career paths may become a more viable option for pharmacy school graduates.


Sooyeon Kwon, PharmD, PhD

Latest:

Exercise Caution Amid the COVID-19 Pandemic

Panic and a host of interactions are entwined with disease-modifying antirheumatic drugs.


Natalie Boytsov, PhD

Latest:

Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare Resources

This study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.



Adam Grana, Frederick Bentzel

Latest:

LinkedIn to Pharmacy: A Student Pharmacist's Guide

Developing industry connections is crucial for aspiring pharmacists.


Ivan Navarro, PharmD candidate

Latest:

Technicians Report Challenges, Successes with ABM Medication Synchronization

The Appointment Based Model (ABM) is a type of medication synchronization where patients have 1 or 2 appointed days a month to pick up their medications.


Paula Bickley, Vice President of Market Access, Biologics by McKesson

Latest:

To Optimize the Patient Journey, Put the Patient First

Without coordinated care to ensure proper adherence, the resulting costs can become downright staggering for health systems.


Bridget T. Regan, MBA, RPh

Latest:

Partnered for Postgraduate Success – SPT & MSPBA

The University of Pittsburgh’s Masters of Science in Pharmacy Business Administration program catalyzes the critical skills and expertise necessary for students to reach their professional goals.


David Kim, PharmD, MPh

Latest:

Migraine-Specific Biologics Treat Severe Headaches

Approved agents target calcitonin gene-related peptides to bring pain relief to affected patients.


Rebecca A. Jayakumar, PharmD

Latest:

Baloxavir Marboxil Treats Acute Influenza in Otherwise Healthy Patients

The newly FDA-approved drug blocks viral replication and RNA transcription via a cap-dependent endonuclease inhibitor.


Thao M. Cong, PharmD Candidate, Cinda Wu, PharmD Candidate

Latest:

Incorporating Vaccination Services into Your Practice

Pharmacists can help achieve immunization goals?especially with influenza and pneumococcal vaccinations?by becoming immunization advocates, facilitators, and/or active immunizers.


Philio D. Hansten, PharmD

Latest:

Does Linezolid Interact with Warfarin?

The antibacterial agent linezolid would not be expected to participate in drug–drug interactions via the cytochrome P450 (CYP) system because it does not appear to be a substrate, inhibitor, or inducer of such isozymes.


Kristen Crossley, Managing Editor

Latest:

FDA Collaborates With Tech Company to Analyze COVID-19 Data

The FDA and Aetion have announced an agreement to collaborate on advanced analytical techniques in an effort to answer urgent research questions about COVID-19.


Sameer Ghate, PhD

Latest:

Resource Use Among Nonvalvular Atrial Fibrillation Patients

This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.




Ruth T. Aguiar, BA

Latest:

Factors Associated With Employee Participation in a Value-Based Insurance Design Initiative

We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.


Alesia Sadosky, PhD, MPH, MBA

Latest:

Trends Associated with Implementing and Lifting a Pregabalin Step Therapy Policy

This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.


Cate Sibley, PharmD

Latest:

Keys to Creating a Healthier and Longer Life

Discover nine overlapping eating habits and lifestyle practices that can help create a healthier, happier, and longer life.


Scott Kemme, SVP, Pharmaceutical Technology & Innovation, McKesson

Latest:

What’s Ahead? Pharmacy Technology Will Drive Patient Care

The pharmacist plays a critical role in supporting the care plan developed between the patient and the physician.


Hemant Phatak, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Gina Columbus

Latest:

Dasatinib Approved for Treatment of Certain Pediatric Patients

The FDA has approved dasatinib (Sprycel, Briston-Myers Squibb) tablets in combination with chemotherapy for the treatment of pediatric patients ≥1 year of age with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).


Kimberly Won, PharmD, BCCCP

Latest:

Vaccinating Adults Amid Crisis Poses Challenges

Pharmacists can greatly contribute to herd immunity during this unprecedented health crisis.